A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

BACKGROUND: Concurrent treatment with temozolomide and radiotherapy followed by maintenance temozolomide is the standard of care for patients with newly diagnosed glioblastoma. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor A, is currently approved for recurr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gilbert, Mark R., Dignam, James J., Armstrong, Terri S., Wefel, Jeffrey S., Blumenthal, Deborah T., Vogelbaum, Michael A., Colman, Howard, Chakravarti, Arnab, Pugh, Stephanie, Won, Minhee, Jeraj, Robert, Brown, Paul D., Jaeckle, Kurt A., Schiff, David, Stieber, Volker W., Brachman, David G., Werner-Wasik, Maria, Tremont-Lukats, Ivo W., Sulman, Erik P., Aldape, Kenneth D., Curran, Walter J., Mehta, Minesh P.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201043/
https://ncbi.nlm.nih.gov/pubmed/24552317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1308573
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars